Interaction Between the Matrix Protein and the Polymerase Complex of Respiratory Syncytial Virus
Viruses · 2024
DOI: 10.3390/v16121881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Elliot B Atchison und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Technology, University of Canberra, Canberra, ACT 2617, Australia. Hauptthemen laut MEDLINE: Antiviral Agents, Respiratory Syncytial Virus, Human, Viral Matrix Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education, Australian Government, University of Canberra Honours Scholarship, Australian Postgraduate Award scholarship.
Abstract (Originalsprache)
The global burden of respiratory syncytial virus (RSV) and severe associated disease is prodigious. RSV-specific vaccines have been launched recently but there is no antiviral medicine commercially available. RSV polymerase (L) protein is one of the promising antiviral targets, along with fusion and nucleocapsid proteins. During medicinal chemistry campaigns, two potent L-protein inhibitors (PC786 and PC751) were identified. Both compounds inhibited the RSV A/B-induced cytopathic effect in HEp-2 cells equally, but PC786 was more potent than PC751 in bronchial epithelial cells. Repeated treatment with escalating concentrations on RSV A2-infected HEp-2 cells revealed both inhibitors led to a Y1631H mutation in the L protein, but only PC786 induced a mutation in the M protein (V153A). By L protein fragment and M protein binding analysis, we showed that the M protein interacts with the 1392–1735 amino acid region of the L protein, where PC786 potentially binds. In addition, PC786 treatment or PC786-induced mutant RSV was found to increase M-protein nuclear localisation later in infection, concomitant with delayed fusion protein localisation at the budding viral filaments. As M protein is known to play a key role in virus assembly and budding late in infection, our data suggests that disrupting the interaction between the M and L proteins could provide a novel target for antiviral development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science and Technology, University of Canberra, Canberra, ACT 2617, Australia.
- Pulmocide Ltd., London WC2A 1AP, UK.
- National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.
ORCID-Profile: Reena Ghildyal
Förderung
- Department of Education, Australian Government
- University of Canberra Honours Scholarship
- Australian Postgraduate Award scholarship
Zitieren
APA
Atchison, E. B., Croft, S. N., Mathew, C., Brookes, D. W., Coates, M., Ito, K., & Ghildyal, R. (2024). Interaction Between the Matrix Protein and the Polymerase Complex of Respiratory Syncytial Virus. Viruses. https://doi.org/10.3390/v16121881
Vancouver
Atchison EB, Croft SN, Mathew C, Brookes DW, Coates M, Ito K, et al. Interaction Between the Matrix Protein and the Polymerase Complex of Respiratory Syncytial Virus. Viruses. 2024. doi:10.3390/v16121881
BibTeX
@article{Atchison2024,
author = {Atchison, Elliot B and Croft, Sarah N and Mathew, Cynthia and Brookes, Daniel W and Coates, Matthew and Ito, Kazuhiro and Ghildyal, Reena},
title = {Interaction Between the Matrix Protein and the Polymerase Complex of Respiratory Syncytial Virus},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121881}
}
EUVIMED